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ABSTRACT Tuberculosis is an infectious and potentially fatal disease caused by the acid-fast bacillus Mycobacterium
tuberculosis (MTB). One hallmark of a tuberculosis infection is the ability of the bacterium to subvert the normal macrophage
defense mechanism of the host immune response. Lipoarabinomannan (LAM), an integral component of the MTB cell wall, is
released when MTBs are taken into phagosomes and has been reported to be involved in the inhibition of phago-lysosomal
(P-L) fusion. However, the physical chemistry of the effects of LAM on lipid membrane structure relative to P-L fusion has not
been studied. We produced membranes in vitro composed of dioleoylphosphatidylcholine, sphingomyelin, and cholesterol to
simulate phagosomal lipid membranes and quantiﬁed the effects of the addition of LAM to these membranes, using
ﬂuorescence resonance energy transfer assays and atomic force microscopy. We found that LAM inhibits vesicle fusion and
markedly alters lipid membrane domain morphology and sphingomyelin-chollesterol/dioleoylphosphatidylcholine ratios. These
data demonstrate that LAM induces a dramatic reorganization of lipid membranes in vitro and clariﬁes the role of LAM in the
inhibition of P-L fusion and the survival of the MTB within the macrophage.
INTRODUCTION
Tuberculosis, one of the major maladies afﬂicting human-
kind (1–3), is an infectious disease caused by Mycobacte-
rium tuberculosis (MTB). The disease afﬂicts ;1/3 of the
human race with over 8 million people becoming infected
every year and2 million people dying from the disease (4).
Drugs such as antibiotics can be used to treat tuberculosis,
but MTB can rapidly develop multidrug resistance (5). Upon
entry into the body, MTB bacilli are engulfed by macro-
phages into phagosomes which would normally fuse with
lysosomes and destroy the invading organism. However, live
MTB bacilli inhibit phago-lysosomal (P-L) fusion, which
subverts this critical initial phase of the macrophage defense
mechanism. Consequently, MTB escape the normal acidiﬁ-
cation process that occurs within the phagosome, permitting
them to survive and reproduce.
In addition to peptidoglycans, glycolipids, protein, and
lipids, MTBs also contain two unique cell wall lipids (6), a
lipoarabinomannan (LAM), and a sulfolipid (7,8). It has
been proposed (9–11) that LAM, a 17-kD molecular mass
lipoglycan with mannan and arabinan groups and a multi-
glycosylated extension of a phosphatidylinositol mannoside
(12) may be involved in the inhibition of P-L fusion.
Speciﬁcally, the mannose cap portion of LAM is considered
to be essential for the inhibition of P-L fusion (13). Although
LAM inhibits increases in cytosolic Ca21, which induces
phagosome maturation (14) and activates phosphatidylino-
sitol 3-kinase (15) which inhibits apoptosis, there are no data
concerning the possible role of LAM on membrane proper-
ties and the P-L fusion process. A similar situation exists
with respect to the MTB sulfolipid (16). However, no major
differences in either pathogenicity or growth have been
found between sulfolipid-deﬁcient MTB mutants and wild-
type MTB (17) implying that the sulfolipid does not play a
role in the inhibition of P-L fusion.
Human alveolar macrophage phagosomal membranes are
derived from and have a lipid composition similar to plasma
membranes, i.e., 31% (w/w) phosphatidylcholine (PC),
21% (w/w) phosphatidylethanolamine (PE), 6.6% (w/w)
sphingomyelin (SM), and7.9% (w/w) cholesterol (chol) (18).
Chol plays a major role in mycobacterial host cell interactions;
MTB cannot invade chol-deﬁcient macrophages in vitro (19).
However, if phagosomes are chol depleted in vitro with methyl-
b-cyclodextrin, an aspartate-containing MTB coat protein
(tryptophane aspartate-containing coat protein, TACO) pro-
motes MTB-phagosome association and P-L fusion (19,20).
These phenomena imply that the presence or absence of chol
can markedly inﬂuence P-L fusion. Therefore, the presence
of LAM and its recruitment into chol-depleted lipid micro-
domains may be sufﬁcient to change the overall membrane
domain structure, resulting in an inhibition of P-L fusion. Here
we present the results of a multiparametric study of the effects
ofLAMon lipid domain formationusing phagosome-mimicking
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membranes produced in vitro to elucidate a possible mechanism
whereby LAM inhibits lipid vesicle fusion.
MATERIALS AND METHODS
Materials
1,2-Dioleoyl-sn-glycerol-3-phosphocholine (DOPC), 1,2-dioleoyl-sn-glyc-
ero-3-phosphoethanolamine (DOPE), SM (chicken egg derived), chol, and
1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N- (Lissamine Rhoda-
mine B Sulfonyl) (N-Rh-PE) were purchased from Avanti Polar Lipids
(Alabaster, AL). LAM (Lot M3N9754) was purchased from NACALAI TE
SQUE (Kyoto, Japan). V-1 grade muscovite mica (Lot 1090115) was
purchased from Structure Probe (West Chester, PA). N-(7-nitrobenz-2-oxa-
1,3-diazol-4-yl)- 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanol-amine,
triethylammonium salt (N-NBD-PE) was purchased from Invitrogen
(Carlsbad, CA). Reagent grade chloroform and methanol were purchased
fromMallinckrodt Baker (Phillipsburg, NJ). Polyethylene glycol 8000 (PEG
8000) was purchased from Fisher Scientiﬁc Company (Pittsburgh, PA).
Liposome preparation
The DOPC/SM ratio was adjusted to 1:1 (mol/mol %) and the chol
concentration was adjusted to 30 mol % of DOPC1SM in a 3:1 chloroform/
methanol solution. The total lipid concentration (DOPC1SM1chol) for
ﬂuorescence resonance energy transfer (FRET) was 0.52 mM, and for
atomic force microscopy (AFM) measurements it was 1 mg/ml. The LAM
concentration was adjusted to 1.8% (w/w) of the three-lipid mixture based
on the biochemical data of the tuberculosis cell wall (21): we estimated that
LAM concentration is 1.57% to 3.74% for total lipids of tuberculosis. The
solvent was removed using a stream of Ar gas, and the lipid mixture was
dried overnight in a vacuum desiccator (102 torr). The dried lipid ﬁlms
were hydrated in Tris-Cl buffer (pH 7.4) at 50C for 1 h and converted to
multilamellar vesicles by vortexing. Large unilamellar vesicles (LUVs) were
prepared by 21 extrusion cycles with an Avanti Polar Lipid extruder at 50C
using a 0.1-mm pore size polycarbonate membrane (Whatman, Florham
Park, NJ). The protocol used to prepare samples for FRET assays was the
same as used to prepare dynamic light scattering (DLS) and AFM samples
except that 0.5 mol % of the ﬂuorescent probes N-NBD-PE and N-Rh-PE
were incorporated into one of the vesicle samples.
Thin-layer chromatography sample preparation
A 500 mL sample of LAM-containing vesicles prepared as described above
was placed in the upper chamber of a Nanosep Omega spin ﬁlter tube with a
molecular mass cutoff of 300 kDa (35-nm pore size, nominal biomolecular
size 90–200 nm) (Cat No. OD300C33; Pall, Ann Arbor, MI). The sample
was centrifuged at 4000 rpm for 20 min based on the results of control
experiments (see Results) followed by three washes of the ﬁlter with 500 mL
of a 50 mM NaCl solution. The four samples from the lower chamber below
the ﬁlter were stored in separate vials for analyses; the ﬁrst sample was
labeled as BOTTOM. Finally, the upper chamber above the ﬁlter was rinsed
once again with 500 mL of a 50 mM NaCl solution, collected, pooled, and
labeled as TOP.
Methods
TLC analyses
A LAM standard in the range of 0.5–1 mg was applied to thin-layer
chromatography (TLC) plates (silica gel 60, 5 3 10 cm; EMD Chemicals,
Gibbstown, NJ). The plates were developed in chloroform/methanol 0.22%
(w/v) CaCl2 (aq) at 65:35:8 (vol). LAM was visualized by spraying the
plates with a solution of 0.2% orcinol (Sigma, St. Louis, MO) in 4 N sulfuric
acid (Sigma) and heating at 110C. The lipids were visualized by spraying
with a solution containing 10% copper sulfate (w/v) (Sigma) and 10%
phosphoric acid (w/v) (Sigma) followed by charring at 120C.
Dynamic light scattering measurements
Determinations of lipid vesicle size were performed by DLS at 25C 6
0.1C using a Malvern Zetasizer 3000HS photon correlation spectrometer
with a 256-channel Malvern 7132 correlator (Malvern Instruments,
Southborough, MA). The instrument uses a 5 mW He-Ne laser source at
632.8 nm and a ﬁxed scattering angle of 90. LAM () and LAM (1) lipid
vesicle samples were prepared as described above and diluted to 1.25 3
102 mg/ml with a preﬁltered, particle-free 50 mM NaCl solution. The
samples were sealed in standard glass cuvettes for analysis. Dilution and
sample transfer were performed on a Class 100 laminar-ﬂow clean bench. A
minimum of 10 measurements of each sample were averaged to generate
mean size distributions. Automatic instrument settings were used to select
the measurement duration for a determination of the photon autocorrelation
function, g2(t). Analyses of the measured correlation functions yielded the
diffusion coefﬁcients of the scatterers (22), which, assuming a spherical
geometry, were converted to particle sizes using the Stokes-Einstein relation
D ¼ kT=3phdH; where D is the translational diffusion coefﬁcient of the
scatterer, k is Boltzmann’s constant, T is the absolute temperature, h is
the viscosity of the medium, and dH is the hydrodynamic diameter of the
particle.
We used two methods of analysis to extract size information from the
measured correlation functions. The method of cumulants (23) was used to
calculate the z-average hydrodynamic diameter and the polydispersity index
(PI). The latter describes the width of the z-average distribution. The method
of cumulants is the basis for the determination of the average DLS diameter
as deﬁned by international standard (ISO 13321: particle size analysis-
photon correlation spectroscopy). A second method, using a nonnegatively
constrained least squares (NNLS) deconvolution algorithm (23) supplied
with the instrument, was employed to generate intensity-weighted particle
distributions.
The resulting distributions were ﬁtted with a lognormal function using
Origin ver. 7.5J (Origin Lab, Northampton, MA) to obtain the modal
diameter.
Fluorescence resonance energy transfer assays
We prepared two vesicle samples. One of the samples contained two
ﬂuorescent probes (N-NBD-PE and N-Rh-PE); the other sample was probe-
free. Vesicle fusion was monitored by FRET between the donor (N-NBD-
PE) and the receptor (N-Rh-PE) molecules (24). All ﬂuorescence measure-
ments were made using a ﬂuorescence spectrophotometer (F-4500, Tokyo,
Hitachi, Japan). PEG 8000 was used as a fusion-inducing agent to obtain a
maximum fusion rate (25). Sample temperature was maintained at 26C with
a temperature-controlled, circulating water bath. The ﬂuorescent probes
were excited at 480 nm, and emission intensity was detected at 580 nm. Data
were plotted and analyzed using Origin 7.5J.
Atomic force microscopy
Supported membrane bilayers, both LAM () and LAM (1), were prepared
on mica by spontaneous vesicle fusion at either room temperature or 50C
for 3–10 min as described previously (26). Images were obtained by liquid-
tapping mode AFM at a scan rate of 1.5 Hz using a multimode AFM, a
type D scanner, a Nanoscope IIIa controller, and silicon nitride DNP-S
probes with a nominal spring constant of 0.58 N/m (Digital Instruments,
Veeco Metrology, Santa Barbara, CA). AFM was performed at 5C, 26C,
or 37C in a custom-built, temperature-controlled environmental chamber
(modiﬁed Model EC02; Sun Electronic Systems, Titusville, FL). The AFM
images were stored in a 512 3 512 pixel format and converted to an 8-bit
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linear gray scale tagged image ﬁle format for image analyses. Domain size
and height analyses were performed using Image Pro Plus, version 4.5
(Media Cybernetics, Silver Spring, MD). The perimeter and area data for
each domain were analyzed using a multipeak Gaussian window model
and statistical analyses of numeric data were carried out using Origin 7.5J.
All size measurements were corrected for the effect of AFM probe tip
broadening (27).
RESULTS
Incorporation of LAM in DOPC-SM-chol vesicle
LAM contains polysaccharide making it hydrophilic and less
soluble in organic solvents. Consequently, since we used a
conventional method to prepare vesicles that involved
organic solvents to mix the lipid components, it was
necessary to verify the incorporation of LAM into the
vesicle bilayer. In a control TLC study a 50 mM NaCl
solution of free LAM was spin-ﬁltered at three centrifugal
speeds (i.e., 3000, 3500, and 4000 rpm) using a 300 kDa
ﬁlter. LAM passed through the ﬁlter at all three speeds (Fig.
1 A, BOTTOM). However, at 3000 rpm, a small portion of
the LAM remained above the ﬁlter in the TOP portion; below
3000 rpm a large portion of the LAM solution remained in
the top compartment (data not shown). TLC analyses using
standards demonstrated that the LAM remained at the origin
on the plate probably due to its large size, degree of
glycolysation, and strong hydrophilicity.
SM, DOPC, and Chol were visualized in both the TOP and
BOTTOM fractions on the copper sulfate-treated charred
plate (Fig. 1 B), demonstrating that some vesicles passed
through the ﬁlter (Fig. 1 B, left 2 lanes). However, lower
amounts of SM, DOPC, and Chol were detected in the
BOTTOM sample of LAM-containing vesicles than the
corresponding TOP sample, implying that a larger number of
LAM-containing vesicles were retained above the ﬁlter than
passed through it (Fig. 1 B, right 2 lanes). This indicates that
the incorporation of LAM into lipid vesicles either increased
vesicle membrane rigidity and effective size or modiﬁed
their surface chemistry, resulting in a stronger interaction
with the ﬁlter which impeded their passage. In contrast, the
orcinol-mediated LAM visualization method demonstrated
that free LAM can pass through the ﬁlter even though control
vesicles coexist in the suspension (Fig. 1 C, left 2 lanes). In
the LAM-containing sample, a darker LAM spot in the TOP
compartment was detected compared to the BOTTOM
compartment (Fig. 1 C, right 2 lanes). Since free LAM
molecules can pass through the ﬁlter but LAM-containing
vesicles cannot under these conditions, these data demon-
strate that LAM can be successfully incorporated on or into
lipid vesicles using a conventional LUV preparation method.
DLS characterization of the effects of LAM
on vesicles
We used DLS to determine the three-dimensional hydrody-
namic sizes of LAM () and LAM (1) LUVs. DLS
characterizes the surface topography of an object based on a
z-average of the vesicle diameters. We found that the
z-average vesicle diameter of LAM () LUVs was 133.4 6
1.1 nm (mean 6 SE) and of LAM (1) LUVs was 143.8 6
1.6 nm. The data were well described as lognormal
distributions (Fig. 2). The peak values of these distributions
FIGURE 1 TLC analyses on the effects of centrifugal force
and ﬁlter pore size on the incorporation of LAM into lipid
vesicle membranes using spin ﬁltration with a 300 kDa cutoff
ﬁlter. (A) The majority of free LAM passed through the ﬁlter.
LAM appeared in the BOTTOM fraction at 3500 rpm or
higher. However, a small portion of the LAM remained in the
top compartment. The yellow spot present in the BOTTOM
fraction (top of plate) is glycerol, a ‘‘wetting’’ agent present in
the spin ﬁlter which reacts with Orcinol. (B) Vesicles can
migrate through the ﬁlter at 4000 rpm. Although they were
present in both the BOTTOM and TOP fractions, a higher
proportion of LAM-containing vesicles remained in the TOP
compartment of the ﬁlter. The faint spot below the chol spot
(top, LAM vesicle fraction) probably represents oxidized chol
derivatives. (C) Using the same sample preparation conditions
presented in B, free LAM in the ‘‘control1LAM’’ sample
appeared in the BOTTOM ﬁlter compartment. In the LAM-
containing sample, a higher concentration of LAMwas present
in the TOP ﬁlter compartment. A weaker LAM spot in the
BOTTOM ﬁlter compartment represents LAM in ‘‘ﬁltered’’
vesicles. A free LAM standard is shown on the right. The TLC
plate was developed with a chloroform/methanol 0.22% (w/v)
CaCl2(aq) at 65:35:8 (vol) solvent system, and LAM was
visualized using a 0.2% orcinol in 4 N sulfuric acid solution
followed by heating at 110C. B, BOTTOM; T, TOP;
‘‘control’’, LAM-free vesicles.
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for LAM () and LAM (1) vesicles were 137.96 0.9 nm and
150.7 6 0.9 nm, respectively. The difference in diameters
may identify a portion of LAMmolecule protruding out of the
vesicle. We used a spherical-shell model of LAM molecules
and vesicles to evaluate the size differences between LAM
()- and LAM (1)-containing vesicles (APPENDIX A). The
model is based on the assumption that a symmetric distribu-
tion of LAM between the outside and inside leaﬂets of the
lipidmembrane resulted in a diameter of 138 nm for LAM ()
vesicles and 151 nm for LAM (1) vesicles (APPENDIX B).
These values are indistinguishable from the values obtained
by DLS. Therefore, we concluded that LAM molecules are
incorporated into the lipid bilayer and the water-soluble sugar
moiety of the LAM molecule is exposed to the aqueous
environment.
FRET characterization of the effects of LAM
on vesicles
It has been reported that MTB releases LAM within a
phagosome where it is subsequently transported to the
cytosol and plasma membrane (11) and inhibits phagosome
maturation, allowing MTB to avoid the lethally low pH of an
antibacterial environment. This was the motivation to
conduct a FRET study of the effect of LAM on vesicle
fusion. In the absence of LAM, rhodamine ﬂuorescence
intensity increased along with the PEG concentration change
(5–15 wt %), but few fusions occurred at 5% of PEG (Fig. 3
A). In contrast, ﬂuorescence intensities of LAM-containing
samples were lower than those at equivalent PEG concen-
trations in the LAM-free system (Fig. 3 B). When the PEG
concentration was increased to 15 wt %, a much higher
fusion rate was seen in the LAM (1) sample, demonstrating
that high levels of PEG can overcame the inhibitory effects
of LAM. In both LAM () and LAM (1), increasing PEG
concentration resulted in higher ﬂuorescence ﬂuctuations.
However, an addition of LAM suppressed the level of
ﬂuctuations in all PEG concentrations as compared to LAM
() samples. In addition, ﬂuorescence intensities in LAM
(1) reached plateau much earlier than in LAM () at all
PEG concentrations.
Fig. 3 C shows that the comparison of FRET signals
intensities at 10 wt % PEG. In the absence of LAM, the
rhodamine ﬂuorescence intensity increased by 12% and
reached a plateau in 50 min. However, in the presence of
LAM the ﬂuorescence intensity increased only2% (plateau
reached at 12–13 min). From Fig. 3, A–C, LAM clearly
demonstrates inhibition of PEG-induced vesicle adhesion or
fusion or both.
AFM characterization of the effects of LAM on
DOPC-SM domains
Giocondi et al. (28) demonstrated the occurrence of the
phase separation between DOPC and SM by AFM. Our
AFM analyses demonstrated that phase separations in similar
domain structures also could be inﬂuenced by the addition of
LAM. In the absence of LAM, a phase separation between
DOPC and SM (Fig. 4 A) occurred as a consequence of the
difference in the phase transition temperature of the in-
dividual lipid components in the mixture. The height dif-
ference between the two phases was 0.98 nm. However, in
the presence of LAM, the size of SM domains increased
whereas the total area occupied by the SM domains
decreased 70% (Fig. 4 B). Fig. 4, C and D, shows enlarged
views of Fig. 4, A and B, respectively, and Fig. 4, E and F,
shows the cross sections of domains in Fig. 4, C and D,
respectively. There is no apparent difference of domain
height at 26C between LAM () and LAM (1). The
domains were stable at this temperature for at least several
hours, and their morphology did not change as a result of
repeated scanning (data not shown).
With LAM (1) DOPC-SM samples, we observed mem-
brane structures ranging in size from 9.5 to 120 nm, and
the height range was 2–7.7 nm. Structures with 120 nm
width probably represent aggregates resulting from unfused
vesicles. A heterogeneous group of structures with an overall
mean population size ranging 17–40 nm probably contains
LAM and are similar to previously described supramolecular
structures produced by self-assembly (29). Structures in the
9.5 nm range probably represent monomers, dimers, or
small polymers of LAM. Considering the fact that a single
bilayer is5 nm thick (26), the height data suggest that these
dots include both LAM self-assembled polymers and that
compressed and/or deformed vesicles occurred during the
membrane fusion process leading to a supported planer
membrane (30). There would be a value slightly lower (7.7
nm) than double membrane (5 nm1 5 nm) as a consequence
of compression of unfused vesicles by AFM probe.
FIGURE 2 DLS assay demonstrates that LAM modulates vesicle diam-
eter size. In the absence of LAM (dotted line), the peak value occurred at 138
nm; in the presence of LAM (solid line), the peak value shifted to 151 nm.
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It is reasonable to presume that the inositol portion of
LAM is in the chol-rich fraction of the domain, and self-
assembled LAM polymers are present in domains containing
DOPC and SM, although we could not detect by AFM either
individual LAM headgroups or their location, possibly due
to the compression of long LAM headgroups by AFM
probes. Our AFM data support and extend our FRET data,
demonstrating that the presence of LAM modulates topo-
graphic properties of the membrane, increases phase sepa-
rations, and inhibits vesicle fusion.
AFM characterization of the effects of LAM on
Chol-containing DOPC-SM domains
Chol is an important constituent of macrophage membranes
(18) and modulates MTB invasion (19). It has been shown
by AFM that SM-chol domains are taller than DOPC
domains (31). These height differences allowed us to
quantify the effects of the addition of chol on DOPC-SM
domain structures. The membrane height difference between
LAM () and LAM (1) was 0.63 6 0.20 nm (Fig. 5 E) and
0.646 0.08 nm (Fig. 5 F), respectively. The presence of chol
in SM-chol domains should result in a change in domain
structure. However, the total area occupied by SM domains
with or without chol was essentially the same (Figs. 4 A and
5 A). In contrast, when LAMwas included in the DOPC-SM-
chol mixture, the SM-chol domain size decreased and the
domain peripheries become very irregular (Fig. 5 B), im-
plying that the inclusion of LAM also modulates and disrupts
SM-chol domains.
Temperature also modulated the topographic properties of
the membrane domains. At 5C, in the absence of LAM (Fig.
6 A) the SM-chol domains were continuous and occupied a
major portion of the membrane surface; at 26C (Fig. 6 B)
and 37C (Fig. 6 C), the SM-chol domains decreased in size
by 35% and 70%, respectively. However, in the presence of
LAM, the SM-chol domains also occupied a major portion of
the membrane at 5C (Fig. 6 D) and again became smaller at
26C (Fig. 6 E). The majority of these domains were
interconnected and instead of simply decreasing in size, they
became fragmented. This phenomenon was even more
evident at 37C where the domains took on a lace-like
appearance (Fig. 6 F). Table 1 shows the effect of
temperature on domain height in LAM () and LAM (1).
Both in LAM () and LAM (1) samples, SM-chol domain
height decreased with an increase of temperature. At 5C,
domain height in LAM (1) was higher than that in LAM
(). However, at 26C and 37C, domain heights are
essentially indistinguishable between LAM () and LAM
(1). Therefore, the decrease in domain height of LAM (1)
from 5C to 26C was more than twofold that of LAM ().
The relationships between temperature and the surface
coverage of the SM-chol/DOPC domain with or without
LAM are shown in Fig. 7 A. The surface coverage by SM-
chol domains in LAM (1) is larger than LAM () at each
FIGURE 3 FRET assays of the ﬂuorescence intensity proﬁles of (A) LAM
() and LAM (1) (B) vesicles demonstrate that LAM inhibits PEG-induced
vesicle fusion. Changes in ﬂuorescence intensity with respect to PEG
concentrations (5, 10, 15 wt %) are shown. Fluorescence intensity was
slightly decreased at 5% PEG in LAM (1) (B), due to possible vesicle
aggregations occurring locally. (C) A comparison of ﬂuorescence intensity
with and without LAM at 10 wt % PEG. In the case of LAM () vesicles, the
ﬂuorescence intensity increased continuously and reached a plateau at 50
min. However, in LAM (1) vesicles there was only a slight change in
ﬂuorescence intensity.
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temperature, especially at 37C: the difference of the surface
coverage is more than 20%. To illustrate the dynamic change
of domain surface coverage with temperature change, we
also plotted ratios between SM-chol and DOPC domains
with respect to temperature (Fig. 7 B). In the absence of
LAM, the SM-chol/DOPC domain ratio decreased linearly
as a function of temperature. In contrast, in the presence of
LAM the domain ratio decreased exponentially. These
results demonstrate that LAM prevents the phase separation
process and alters SM-chol/DOPC domain ratios over a phy-
siological temperature range even though changes in domain
shape occurred.
Fig. 8, A and B, shows the length and area of each SM-
chol domain in LAM () and LAM (1) samples. Although
some domains in LAM (1) showed higher length and area,
the majority of domains had similar length and area values
(Fig. 8, B and C). Therefore, we used the concept which
evaluates the complexity of domain shape (Fig. 8 C) on a
one-to-one basis. When object shape becomes more complex
than the circle while keeping the same area, the perimeter of
the object increases beyond 2pr, where r is the radius of the
original circle. Therefore, the difference between the domain
perimeter and 2pr can be a measure of the level of
complexity of domain shape. Based on this concept, we
analyzed the area/length histogram by multipeak Gaussian
ﬁtting: two peaks appeared both in the presence and absence
of LAM (Fig. 8, D and E). In the absence of LAM, the peaks
occurred at 7.7 6 1.4 (nm1) and 12.9 6 0.9 (nm1) (Fig. 8
D). In the presence of LAM, the peaks occurred at 12.86 0.5
(nm1) and 21.4 6 0.7 (nm1) (Fig. 8 E). Table 2
summarizes the perimeter/area population ratios with or
without LAM at three different temperatures. At 5C, the
positions of the LAM () and LAM (1) peaks were
statistically indistinguishable. At 26C, although the LAM
(1) peaks shifted to higher values than at 5C, there was still
no signiﬁcant different between the 5C and 26C values of
the LAM () peaks. However, at 37C, the LAM (1) peak
values were signiﬁcantly higher than LAM () peak values,
conﬁrming the observation that LAM (1) membrane domain
irregularities dramatically increased. These data demonstrate
that LAM directly affects the phase behavior of the lipid
bilayer, more speciﬁcally, domain formation or phase
separation, probably by modulating intermolecular interac-
tions between the lipid species.
DISCUSSION
LAM in cytoplasm membrane
LAM is known to be released from MTB into phagosome
and transported to cytoplasm via phagosomal membrane (2).
Furthermore, Shabaana et al. reported that soluble LAM is
FIGURE 4 In contrast to the exclusion of LAM () (A),
the inclusion of LAM (1) (B) into DOPC-SM-chol
membrane vesicles resulted in the appearance of larger
domains as well as an increased number of small unfused
vesicles. C and D are enlarged views of A and B,
respectively. E and F show cross sections of SM-chol
domains, respectively. A multipeak Gaussian ﬁtting anal-
ysis was used to obtain domain height based on optical
density differences of the image.
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passively incorporated into the raft domain of vesicle mem-
brane (32). When living MTB is captured into phagosome,
the phagosomal-lysosomal fusion does not occur. Taken
together, LAM may spontaneously insert into the phagoso-
mal membrane, including its outer leaﬂet, of the infected
macrophage and modulate the lipid membrane properties and
fusion process.
Two steps of inhibition of membrane fusion
by LAM
We focused on the effects of LAM on lipid domain structure
and its relation to the inhibition of P-L fusion and demon-
strated that LAM inhibits PEG-induced lipid vesicle fusion
with FRET in vitro (Fig. 3 and Supplementary Material). An
increase in ﬂuorescence intensity provides direct proof that
vesicle fusions occurred in the presence of PEG. In our
FRET system, the ﬂuorescence probe N-Rh-PE acts as an
acceptor and emits light as a consequence of energy transfer
from the N-NBD-PE donor probe. If vesicle aggregation
and/or lysis occurs between probe (1)-vesicles and probe
()-vesicles, N-Rh-PE-induced ﬂuorescence intensity would
not occur.
In general, the membrane fusion mechanism can be
divided into two steps: the ﬁrst step is vesicle adhesion and
the second step is actual vesicle fusion process. The function
of PEG in this system is to absorb water molecules around
the lipid vesicles and promote membrane associations. In
Fig. 3, we demonstrated that LAM inhibits PEG-induced
vesicle fusion. Moreover, not only is absolute intensity lower
with LAM, but the time required for reaching plateau is also
signiﬁcantly shorter in the presence of LAM compared to
LAM (). These data suggest multiple effects by LAM on
fusion process. In fact, another lipid system with PE, which
is known as a fusion promoter due to its molecular structure
(33), also showed inhibition by LAM (Supplemental Material
and Fig. 3) with a different FRET signal pattern. Fluores-
cence intensities smoothly increased with time in both LAM
(1) and LAM () with PE. However, the ﬂuorescence
intensities are inhibited strongly by LAM in the presence of
PE. These data may demonstrate that LAM modulates not
only vesicle adhesion but also the after membrane fusion
process.
The ﬁrst step: inhibition of vesicle association
Lower FRET signals with LAM and its enhancement by
increase in PEG concentration (Fig. 3) show that LAM
effectively reduces the association level of adjacent vesicles.
The inhibition of vesicle association in the presence of LAM
FIGURE 5 The absence (A) or presence (B) of LAM
from lipid membranes resulted in clear changes in lipid
domain size and morphology at 26C. In the absence of
LAM, the addition of chol resulted in an increase in
domain size. However, when LAM was added to a DOPC-
SM-chol membrane, the SM-chol domains decreased in
size and their periphery became markedly irregular. C and
D are enlarged views of A and B, respectively. E and F
show the cross sections of SM-chol domains. A multipeak
Gaussian ﬁtting analysis was used to obtain domain height
based on optical density differences of the image.
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could be a consequence of either the inability of PEG to
extract water molecules from LAM-containing lipid vesicles
and/or an obstruction of vesicle fusion by the long sugar
chains present in the LAM molecules. Detailed mechanisms
of the LAM-induced reductions in vesicle association
remains to be studied, but the P-L fusion may also be in-
hibited on association step with a similar mechanism when
LAM is inserted into the phagosomal membrane.
Second fusion step and LAM-induced modulation of
lipid packing
Our AFM data showed that under the same conditions used
in the FRET experiments, LAM dramatically changes the
SM-chol domain size, height, and structure. In addition, the
existence of scattered domains and a nonlinear relationship
between temperature and the SM-chol/DOPC domain ratio
in LAM-containing membranes (Fig. 7 B) are also relevant
and provide notable observations substantiating our model of
the effects of LAM on lipid membranes. These results
increase the possibility that LAM sugar moieties may shield
the dipole moments involved in the interactions between
phospholipids molecules and change the lipid packing array
(34), leading to marked differences in lipid phase behavior at
physiological temperature. As a result, lipid domain forma-
tion and its shape are altered. Furthermore, the coalescence
of small SM-chol domains to form larger domains as well as
the maintenance of lipid-packing conditions in each domain
FIGURE 6 The presence of LAM (D–F) promoted marked SM-chol
domain shape changes over a wide temperature range. In a LAM-free system
(A–C), SM-chol domain size decreased with increasing temperature.
However, the SM-chol domains in a LAM (1) system are highly fragmented
and their shapes became more complex.
TABLE 1 The effect of temperature on domain height with
and without LAM
Temp LAM () (nm) D LAM (1) (nm) D
5C 0.67 6 0.04 7% 0.76 6 0.17 15%
26C 0.63 6 0.20 21% 0.64 6 0.08 19%
37C 0.50 6 0.07 0.52 6 0.13
The height data were obtained by multipeak Gaussian ﬁtting of histograms
constructed based on the optical diffuse contrast of captured AFM images.
Multiple locations over several images were analyzed to obtain statistical
data for each height value. SM-chol domain height became lower by in-
creasing temperature with and without LAM samples. SM-chol domain
height is slightly higher in LAM (1) than LAM () at 5C, and it is
indistinguishable at 26C and 37C.
FIGURE 7 (A) Surface domain (SM-chol) area of LAM () and LAM
(1) at three different temperatures. At all temperatures, the SM-chol domain
area of LAM (1) is larger than that of LAM (). The inclusion of LAM
(solid line) altered DOPC-SM-chol and SM-chol domain ratios over a large
temperature range (B). However, at physiological temperatures, LAM
stabilized SM-chol ratios (dotted line).
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may be restricted by the addition of LAM. Consequently, the
miscibility of lipid molecules in the membrane would be
relatively high, indicating a decrease in the importance of
phase separations that result in more scattered and smaller
SM-chol domains. The irregular domain structures revealed
by AFM (cf. Fig. 5 B, Fig. 6, D–F) and the decreased
sensitivity of domain shape to temperature variations support
this hypothesis and provide critical insight into physical
chemistry involved in LAM-induced inhibition of phospho-
lipid fusion and the increased survival of MTB in humans.
These membrane domain modulations probably have an
impact on the formation of intermediate structures such as
‘‘stalks’’ and/or ‘‘pores’’ after lipid mixing. The complex
three-dimensional structure at the intermediate step may be al-
tered by LAM molecules, resulting in a reduced total vesicle
fusion as shown by FRET data.
How does LAM inhibit P-L fusion in phagosome?
Based upon our cumulative data we can propose several
pathways to explain the mechanism enabling the inhibition
of P-L fusion by LAM. One possibility is that as a
consequence of a LAM-induced modiﬁcation of chol
distribution due to the changes in membrane domain
structure in the phagosomal membrane, TACO cannot
surround and bind to the phagosomal membrane, resulting
in reduced membrane associations. As we discussed above,
FIGURE 8 (A and B) Distributions of perimeter
and area in LAM () and LAM (1) at 37C. No
signiﬁcant difference between LAM () and LAM
(1) in length and area was observed. (C) Concept
for perimeter versus area size. When the object
shape is a perfect circle, the area is 2pr. However,
if object shape becomes intricate, perimeter length
becomes larger than a circle with the same area. At
37C, in comparison to LAM-free vesicles (D), the
shape and morphology of the SM-chol domains in
a DOPC-SM-chol membrane were altered by the
inclusion of LAM (B). SM-chol domains show
two peaks in both LAM () and LAM (1)
systems. However, at 37C, the positions of LAM
(1) peaks shifted to markedly higher values,
implying that the shape of both populations of SM-
chol domains have become increasinglymore com-
plex. An identical change was observed at 26C,
but not at 5C (see Table 2).
TABLE 2 The effect of temperature and LAM on DOPC and
SM-chol domain shape
LAM  LAM 1
Temp (C) Peak 1 Peak 2 Peak 1 Peak 2
5 8.4 6 2.9 13.0 6 4.4 10.2 6 0.3 13.1 6 0.7
26 10.2 6 0.3 13.0 6 0.5 17.2 6 1.2 23.6 6 2.5
37 7.7 6 1.4 12.9 6 0.9 12.8 6 0.5 21.4 6 0.7
Peak values obtained using multipeak Gaussian ﬁtting of perimeter/area
histograms are shown. At 5C, LAM has minimal effect on the position of
domain perimeter/area peaks in DOPC-SM-chol membranes. However,
LAM induced marked increases in the complexity of domain shape at both
26C and 37C.
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an anomalous state of membrane fusion may occur as a con-
sequence of LAM-induced structural changes in the mem-
brane.
The major difference between our in vitro vesicle fusion
and P-L fusion in macrophages is the existence of the soluble
N-ethylmaleimide-sensitive fusion attachment protein receptor
(SNARE, (35)) complex instead of PEG. SNARE proteins
and syntaxins 2, 3, and 4 are present on macrophages (36),
making them potentially involved in the MTB-induced P-L
fusion inhibition process. Based on our observations, it is
possible that the function of SNARE proteins and their
distribution are affected by LAM-induced domain modiﬁ-
cations. Furthermore, it is also possible that SNARE complex
members can be inhibited from interacting with each other
or result in fewer interactions as a consequence of the large
sugar moiety present on LAM, which is analogous to the
reduction of the PEG effect in our in vitro system.
Lenz et al. (37) reported that SNAREs promote lipid
membrane fusion in vitro but do not trigger membrane
fusion. Logical extensions of their observation are 1), the
inner membranes of fusing vesicles form intermediate
structures at an early stage of the PEG-induced lipid vesicle
fusion; 2), while intermediate structures are formed, local
membrane curvature/surface lipid density and line tension
are modulated by additional chol (38), resulting in the
induction of vesicle fusion; and 3), if LAM is present in the
system, LAM should induce an incommodity condition for
the storks model membrane. As we found by AFM, SM-chol
‘‘structural’’ domains become irregularly scattered but more
stable if LAM and chol are distributed in an irregular fashion
in the membrane. As a result of stabilization, local regions of
the membrane (e.g., the chol domain area) become three-
dimensionally more rigid, resulting in the complete inhibi-
tion of vesicle fusion.
There is ample precedence for the premise presented here;
some bacteria have been shown to modulate plasma
membrane and (or) phagosomal membrane lipid rafts to
facilitate their entry and survival in vertebrate cells (39,40).
Therefore, both previous studies and our results support the
possibility that MTB can escape the acidiﬁcation process by
a mechanism involving LAM-induced alterations in micro-
domain size and a concomitant decrease in the functionality
of syntaxins in the liquid disorder phase. Recent studies
demonstrate that sugar moieties and raft modiﬁcations are
also involved in HIV-1 and inﬂuenza infections (41,42).
CONCLUSIONS
In this report, we elucidate that the physicochemical
processes involved in LAM-induced modiﬁcation of raft-
like membrane structures correlate to an inhibition of lipid
vesicle fusion. To our knowledge, this is the ﬁrst demon-
stration that LAM changes the molecular packing efﬁciency
of chol within the SM phase. The dramatic reorganization of
the lipid membrane may be reﬂected in the inhibition of P-L
fusion by MTB, survival of MTB within macrophages, and
the onset of tuberculosis in humans. To understand details of
inhibitory effects by LAM for the membrane fusion, further
in vitro and in vivo systematic studies will be required using
a variety of experimental conditions. Live cell imaging to
study a direct correlation between domain modiﬁcations and
inhibition of P-L fusions in vivo will be the most challenging
work but provides a higher level of understanding. Another
remaining question is what other factors may be involved in
the inhibition of P-L fusion in macrophages. Long-chain
sulfolipids also originate from MTB and may have similar
effects. In summary, our ﬁndings strengthen the premise that
an association exists between high glycolipid levels in MTBs
and their ability to infect macrophages. In addition, it deﬁnes
a possible role for glycolipid regulation in MTB survival.
Absolute domain size differences may exist between in vitro
versus in vivo systems, but these differences do not diminish
the signiﬁcance of our results, which may help in the devel-
opment of unique new chemotherapeutics against MTB.
APPENDIX A
The normalized second-order intensity autocorrelation function determined
by DLS in homodyne detection mode can be expressed as follows (Siegert
relation):
g
ð2ÞðtÞ ¼ B1Ajgð1ÞðtÞj2; (1)
where t is the correlator delay time, B is the baseline value for the
normalized correlation function measured at t/N and should be equal to
1 (subject to noise levels in the measured data), and A is an optical coherence
factor that is instrument dependent but ideally equal to unity. The ﬁrst-order
electric ﬁeld autocorrelation function, g1(t), is directly linked to the
translational diffusion of the scatterers, and for independently diffusing
polydisperse particles can be written in the form of a Laplace transform:
g
ð1ÞðtÞ ¼
Z N
0
GðGÞ3 expðGtÞdG; (2)
where the decay rate G ¼ Dq2; D is the diffusion coefﬁcient,
q ¼ ð4pn=loÞsinðu=2Þ is the scattering vector, n is the refractive index of
the medium, lo is the vacuum laser wavelength, and u is the scattering angle.
The function GðGÞ describes the distribution of decay rates in the particle
population and hence deﬁnes the particle size distribution.
The method of cumulants can be applied to extract information about the
moments of the size distribution. Here the logarithm of g1(t) is expanded in
a series to yield a polynomial in t that can be analyzed by linear least squares
ﬁtting:
ln½g1ðtÞ ¼ K1t1K2
2
t
2 . . . (3)
Only the ﬁrst two terms are retained, whereas higher order terms are
typically omitted. The ﬁrst cumulant, K1 ¼ ÆGæ; yields the z-average particle
size, and the dimensionless ratio, K2=ÆGæ2 (where K2 is the second cumulant),
deﬁnes a PI that characterizes the width of the distribution. For a Gaussian
distribution of decay rates, s2=2 ¼ K2 ¼ PI3 ÆGæ2; where s is the standard
deviation of the distribution.
An inversion algorithm such as NNLS (23) can be used to deconvolute
Eq. 2 and obtain an estimate of GðGÞ: NNLS seeks a nonnegative solution
producing the best ﬁt (minimum ﬁt error) to the experimental data. By
excluding solutions with physically unrealistic negative distribution values,
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NNLS reduces the inherent ill-conditioned nature of Eq. 2, and thereby
enables a larger number of possible solutions to be tested with the result that
better size resolution is achieved. The algorithm yields a robust size
distribution consistent with experimental data but without imposing the
additional smoothness criteria required by regularization algorithms like
CONTIN (43). Oversmoothing of the solution leads to a loss of size
resolution, with the result that a real multimodal distribution might be
represented after data inversion as a broad single peak.
APPENDIX B: SPHERICAL-SHELL MODEL OF
LAM MOLECULES
The hydrodynamic radius of an arbitrary shaped body, RH, can be calculated
following the classical theory of Bloomﬁeld et al. (1967) from a
representation of n spherical shells via the relationship
RHn ¼
+
n
k¼0
ðRkÞ2
 2
+
n
k¼0
ðRkÞ3
 
1 2 +
n
i2¼1
+
i21
i1¼0
ðRi2Þ2ðRi1Þ2
Di2;i1
 ; (4)
where (44) Rk is the radius of the kth spherical shell and Di2,i1 is the distance
between the i2th and i1th spherical shells. The expression is considered to
be exact within the Oseen-Burgers-Kirkwood formalism when the number
n of the total spherical shell approaches inﬁnity.
Our measurements of LAM vesicles are consistent with previous reports
of the properties of LUVs extruded and maintained in a salt solution (26).
Consequently, for a basic hydrodynamic model, we treat each LAM-free
vesicle as one spherical shell of radius RHV ¼ 69.0 nm (Fig. 2).
The molecular structure and hydrodynamics of LAM molecules are not
known in great detail. Furthermore, their hydrodynamic structure when
attached to or incorporated into a membrane can differ from their solution
conﬁguration. Therefore, we start from the basic assumption that each 17
KDa LAM molecule consists predominantly of 30 mannoses and 50
arabinofuranoses and both residues are ring-like water soluble units. The basic
van der Waals dimension of the arabinofuranose unit is about 0.25 nm 3
0.45 nm 3 0.7 nm, the mannose unit is about 20% larger, and the bounded
layer of water molecules is typically 0.3–0.5 nm.
Estimation of the hydrodynamic radius of a
small molecule
The hydrodynamic radius of a small macromolecule can be estimated via the
range, ½Rsv[ 3
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
3V=4p
p
#RH#RSA[
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃðA=4pÞp , where V is volume and
A is the surface area of the molecule with its hydration layer, and the
equalities hold for a spherical shape. Consequently, we can average over the
two units and model each LAMmolecule with 80 equal contacting spherical
unit shells, each with a hydrodynamic radius, Ru ¼ 0.5 nm, in a branched
linear chain. Then, Eq. 4 can be applied to all speciﬁc conformations of such
measured hydrodynamic properties. We numerically solved the case of a
straight line of equal spherical shells and observed an empirical ﬁt that
RHðnÞ[CðnÞ3Ru ﬃ ½ ﬃﬃﬃnp 1 0:0853 ðn 2Þ3Ru;
2# n# 100: (5)
Therefore, for a LAM molecule conﬁgured into a small number of branches
of tens of ring units, we have an acceptably robust estimation that
RHL ﬃ 13Ru ﬃ 6.5 nm.
Spherical-shell model of LAM vesicles
Our DLS measurements on the LAM (1) vesicles are similar to those of
LAM () vesicles except the mean hydrodynamic radius is increased to
RHVL ¼ 75.3 (Fig. 2). We presume that the underlying lipid vesicles are the
same, and only LAM molecules externally attached to the lipid vesicles are
responsible for the increase in the hydrodynamic radius. Eq. 4 can now be
applied to spherical shells of unequal sizes to deduce the number of LAMs
per vesicle. First for one LAMmolecule as a spherical shell of RHLﬃ 6.5 nm
radius attached to the much larger spherical shell of radius RHV ﬃ 69 nm,
Eq. 4 shows directly that the increment from one LAM molecule is dRHL ﬃ
0.052 nm. A linear extrapolation from the dRHL value predicts that a total
of (DRHL /dRHL) ﬃ 122 LAM molecule shells attached to the outside of the
membrane vesicle shell will account for the observed increase in the
hydrodynamic radius. This linear extrapolation is independent of the relative
locations of their representing spherical shells but does not yet account
for any nonlinear multiple LAM shell effects. So as an improvement, we
have considered a uniform placement of multiple LAM molecule shells out-
side of the vesicle shell and solved numerically that it takes nL ﬃ 218
LAM molecules to match the observed size increase, DRHL ¼ RHLV 
RHL ﬃ 6.3 nm. The average distance between these LAM shells is
;
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
4p=nL
p ðRHV1RHLÞ ﬃ 18nm, so that LAM molecule shells are iso-
lated from each other.
Therefore, we can conclude that about 218 LAM molecules are
incorporated into the lipid bilayer with attachment to the outside of our
LAM vesicles. LAMmolecules attached to the inside of lipid vesicles do not
affect hydrodynamic radius and are not directly measured by DSL. From the
extrusion process, it is reasonable to expect a rough symmetry between the
outside and inside leaﬂets of the lipid membrane. Consequently, we predict
that there may be a total of about 436 LAM molecules incorporated into the
underlying lipid LUV(s).
LAM/Lipid ratio in LAM vesicles
To estimate the LAM/lipid ratio, we now calculate the amount of lipids per
LUV. Our LAM () and LAM (1) LUVs were extruded and maintained in a
salt solution and were previously determined to have a certain degree
elongation having the inverse of the elongation factor, p (i.e., the ratio of
short axis b to the long axis a, with a prolate ellipsoid shape approximation)
of ;3 (45). Following classical geometrical relations, we have deduced
an explicit expression for membrane vesicle surface area as
APEðRH; pÞ ¼ 4p3RH2V3 23 SPEðpÞ; where the extra factor of 2 accounts
for the double leaﬂets of the bilayer and the shape function SPE(p) depends
on the vesicle elongation, p. Although our closed expression for SPE(p)
contains both Ln and asin terms and is somewhat lengthy, it can be matched
within 4% by a simple approximation, SPEðpÞ ﬃ p0:85 for 1# p1, 3:5;
such that SPE(p)ﬃ 1, 1.86, and 2.51 for p1¼ 1, 2, and 3, respectively. Thus,
the lipid membrane surface area in our extruded LUV is about 2.5 times that
of a sphere vesicle of radius RH.
Our membrane is composed of DOPC/SM/Chol in the ratio 5:5:3 (see
Methods). Because of the complexity of the phase diagram, the mean surface
area per lipid, AL, is not exactly known, so we make the usual assumption
that ALﬃ 0.7 nm2 per lipid weight ofMWDOPC ﬃ 800 (45). Accordingly, we
can calculate that the weight ratio of LAM to lipid in our LAM (1) LUV(s)
is ; LLW ﬃ 2.2%f¼ 23nL3MWL=ð4pRH2L32:51323MWDOPC=ALÞg.
Considering that our initial sample contained LAMmolecules of 1.8 wt % to
DOPC/SM/Chol, one could conclude that most, if not all, LAM molecules
are incorporated into LUV membranes.
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